NHS staff refusing to use FDP over Palantir ethical concerns
NHS staff resistance to using the new Federated Data Platform has reignited controversy over the UK health service’s £180–330m contract with US data analytics firm Palantir. Commenters question the ethics and legality of handing large-scale patient data to a politically charged American company subject to US surveillance laws, arguing it risks privacy and democratic oversight. Others counter that the NHS’s fragmented, outdated IT landscape desperately needs effective data integration, and see Palantir as a pragmatic if imperfect solution given repeated in‑house failures.
Scope and Cost of the Contract
- Palantir won an NHS Federated Data Platform (FDP) contract quoted in media as £330m; commenters link official notices showing ~£182m over 5 years, with options to extend.
- Debate over whether ~0.02% of the NHS’s annual budget is “nothing” or still a large sum for “operational data collection.”
- Some argue this kind of national-scale data integration for millions of patients is inherently a “billion‑dollar problem”; others see the value as unproven and call for investigation into how the deal was approved.
Palantir’s Role, Ethics, and Capability
- Strong distrust of Palantir due to its close ties to US defense/intelligence and its explicitly political leadership; several see it as part of a broader surveillance-state project.
- Others counter that, technically, it’s just a data platform that can be deployed on client‑controlled infrastructure and is used by multiple governments; they claim no known data leaks and strong security certifications.
- Some report the tech is “meh” by current standards and sustained largely by political access and consulting, not technical moat.
NHS IT, Structure, and Alternatives
- Broad consensus that NHS IT is a mess: fragmented systems across hundreds of trusts, poor interoperability, paper records, fax dependence, and weak in‑house software capability.
- Some argue this justifies bringing in a heavyweight integrator; others say the same money could have built high‑quality open‑source systems or funded better internal teams.
- There is frustration about bureaucratic culture (e.g., difficulty even running Python, “spend the budget or lose it”) and lack of centralized, competent procurement.
Data Privacy, Sovereignty, and Law
- Major concern that, as a US company, Palantir is subject to the CLOUD Act; some argue UK patient data becomes accessible via US legal processes, regardless of where servers sit.
- Others respond that if Palantir only runs software on NHS‑owned infrastructure, exfiltration may be constrained; the exact legal exposure is debated and unclear.
- Several see any transfer of citizen health data to a foreign private entity as a betrayal of public trust and potentially illegal under UK/EU data protection rules.
Staff Resistance and Employment Ethics
- Some insist NHS staff refusing to use FDP are failing in their duties and should be fired; others argue workers are not obliged to cooperate with systems they see as unethical.
- There is disagreement over whether “it’s just business” (employer can fire non‑compliant staff) or whether moral objection in public healthcare warrants civil resistance.
Comparisons and Systemic Critiques
- Repeated comparisons to US healthcare: private systems do not reliably deliver fast access either and are often worse overall, despite far higher spending.
- Critiques that the NHS is structurally inefficient, administratively bloated, underpays clinicians, and increasingly relies on lower‑quality imported staff.
- Some argue simply “funding the NHS more” is misguided without deep structural reform; others stress the importance of universal public provision to keep private offerings honest.